- 如果營收成長率小於推銷費用成長率, 可能代表產品需要很多的促銷才能賣掉, 或是產品有問題需要花額外的推銷成本來善後
- 發展品牌的公司不樂見推銷費用率的下滑, 對此類型公司推銷費用率等同於走技術類型公司的研發費用率
| 營收淨額 QoQ YoY | 推銷費用 QoQ YoY | 管理費用 QoQ YoY | 研發費 QoQ YoY | 推銷費用率(%) QoQ YoY | 管理費用率(%) QoQ YoY | 研發費用率(%) QoQ YoY | 員工人數 QoQ YoY | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23Q4 (20) | 0.01 | 0 | 0 | 0 | 0 | 0 | 0.13 | 62.5 | 44.44 | 0 | 0 | 0 | 0.00 | -100.0 | 0 | 1300.00 | 46885.71 | 85.71 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 23Q3 (19) | 0 | -100.0 | -100.0 | 0 | -100.0 | 0 | 0.08 | 14.29 | 14.29 | 0 | 0 | 0 | 4.35 | 0.0 | 0 | 2.77 | 0.0 | -99.6 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 23Q2 (18) | 2.53 | 0 | 12550.0 | 0.11 | 0 | 0 | 0.07 | 0.0 | 40.0 | 0 | 0 | 0 | 4.35 | 0 | 0 | 2.77 | -99.6 | -98.89 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 23Q1 (17) | 0 | 0 | -100.0 | 0 | 0 | 0 | 0.07 | -22.22 | 40.0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 700.00 | 0.0 | 40.0 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 22Q4 (16) | 0 | -100.0 | -100.0 | 0 | 0 | 0 | 0.09 | 28.57 | 125.0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 700.00 | 0.0 | 425.0 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 22Q3 (15) | 0.01 | -50.0 | -80.0 | 0 | 0 | 0 | 0.07 | 40.0 | 40.0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 700.00 | 180.0 | 600.0 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 22Q2 (14) | 0.02 | 100.0 | 0.0 | 0 | 0 | 0 | 0.05 | 0.0 | 25.0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 250.00 | -50.0 | 25.0 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 22Q1 (13) | 0.01 | -66.67 | -90.0 | 0 | 0 | 0 | 0.05 | 25.0 | 25.0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 500.00 | 275.0 | 1150.0 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 21Q4 (12) | 0.03 | -40.0 | -75.0 | 0 | 0 | 0 | 0.04 | -20.0 | 0.0 | 0 | 0 | 0 | 0.00 | 0 | 0 | 133.33 | 33.33 | 300.0 | 0.00 | 0 | 0 | 0 | 0 | 0 |
| 21Q3 (11) | 0.05 | 150.0 | -50.0 | 0 | 0 | 0 | 0.05 | 25.0 | -28.57 | 0 | 0 | -100.0 | 0.00 | 0 | 0 | 100.00 | -50.0 | 42.86 | 0.00 | 0 | -100.0 | 0 | 0 | 0 |
| 21Q2 (10) | 0.02 | -80.0 | -33.33 | 0 | 0 | 0 | 0.04 | 0.0 | -42.86 | 0 | 0 | -100.0 | 0.00 | 0 | 0 | 200.00 | 400.0 | -14.29 | 0.00 | 0 | -100.0 | 0 | 0 | 0 |
| 21Q1 (9) | 0.1 | -16.67 | 11.11 | 0 | 0 | 0 | 0.04 | 0.0 | -20.0 | 0 | 0 | -100.0 | 0.00 | 0 | 0 | 40.00 | 20.0 | -28.0 | 0.00 | 0 | -100.0 | 0 | 0 | 0 |
| 20Q4 (8) | 0.12 | 20.0 | 200.0 | 0 | 0 | 0 | 0.04 | -42.86 | -20.0 | 0 | -100.0 | -100.0 | 0.00 | 0 | 0 | 33.33 | -52.38 | -73.33 | 0.00 | -100.0 | -100.0 | 0 | 0 | 0 |
| 20Q3 (7) | 0.1 | 233.33 | 150.0 | 0 | 0 | 0 | 0.07 | 0.0 | 16.67 | 0.02 | 100.0 | -33.33 | 0.00 | 0 | 0 | 70.00 | -70.0 | -53.33 | 20.00 | -40.0 | -73.33 | 0 | 0 | 0 |
| 20Q2 (6) | 0.03 | -66.67 | -50.0 | 0 | 0 | 0 | 0.07 | 40.0 | 16.67 | 0.01 | -75.0 | -66.67 | 0.00 | 0 | 0 | 233.33 | 320.0 | 133.33 | 33.33 | -25.0 | -33.33 | 0 | 0 | 0 |
| 20Q1 (5) | 0.09 | 125.0 | 28.57 | 0 | 0 | 0 | 0.05 | 0.0 | -28.57 | 0.04 | 33.33 | 33.33 | 0.00 | 0 | 0 | 55.56 | -55.56 | -44.44 | 44.44 | -40.74 | 3.7 | 0 | 0 | 0 |
| 19Q4 (4) | 0.04 | 0.0 | 0.0 | 0 | 0 | 0.0 | 0.05 | -16.67 | 0.0 | 0.03 | 0.0 | 0.0 | 0.00 | 0 | 0.0 | 125.00 | -16.67 | 0.0 | 75.00 | 0.0 | 0.0 | 0 | 0 | 0.0 |
| 19Q3 (3) | 0.04 | -33.33 | 0.0 | 0 | 0 | 0.0 | 0.06 | 0.0 | 0.0 | 0.03 | 0.0 | 0.0 | 0.00 | 0 | 0.0 | 150.00 | 50.0 | 0.0 | 75.00 | 50.0 | 0.0 | 0 | 0 | 0.0 |
| 19Q2 (2) | 0.06 | -14.29 | 0.0 | 0 | 0 | 0.0 | 0.06 | -14.29 | 0.0 | 0.03 | 0.0 | 0.0 | 0.00 | 0 | 0.0 | 100.00 | 0.0 | 0.0 | 50.00 | 16.67 | 0.0 | 0 | 0 | 0.0 |
| 19Q1 (1) | 0.07 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0.07 | 0.0 | 0.0 | 0.03 | 0.0 | 0.0 | 0.00 | 0.0 | 0.0 | 100.00 | 0.0 | 0.0 | 42.86 | 0.0 | 0.0 | 0 | 0.0 | 0.0 |
| 營收淨額 YoY | 推銷費用 YoY | 管理費用 YoY | 研發費 YoY | 推銷費用率(%) YoY | 管理費用率(%) YoY | 研發費用率(%) YoY | 員工人數 YoY | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 2.55 | 6275.0 | 0.11 | 0 | 0.35 | 40.0 | 0 | 0 | 4.31 | 0 | 13.73 | -97.8 | 0.00 | 0 | 0 | 0 |
| 2022 (9) | 0.04 | -78.95 | 0 | 0 | 0.25 | 47.06 | 0 | 0 | 0.00 | 0 | 625.00 | 598.53 | 0.00 | 0 | 0 | 0 |
| 2021 (8) | 0.19 | -44.12 | 0 | 0 | 0.17 | -29.17 | 0 | 0 | 0.00 | 0 | 89.47 | 26.75 | 0.00 | 0 | 0 | 0 |
| 2020 (7) | 0.34 | 61.9 | 0.01 | 0 | 0.24 | 0.0 | 0.07 | -46.15 | 2.94 | 0 | 70.59 | -38.24 | 20.59 | -66.74 | 0 | 0 |
| 2019 (6) | 0.21 | -77.17 | 0 | 0 | 0.24 | -17.24 | 0.13 | -43.48 | 0.00 | 0 | 114.29 | 262.56 | 61.90 | 147.62 | 0 | 0 |
| 2018 (5) | 0.92 | 80.39 | 0 | 0 | 0.29 | -9.38 | 0.23 | -11.54 | 0.00 | 0 | 31.52 | -49.76 | 25.00 | -50.96 | 0 | 0 |
| 2017 (4) | 0.51 | 0.0 | 0.02 | -60.0 | 0.32 | -23.81 | 0.26 | -25.71 | 3.92 | -60.0 | 62.75 | -23.81 | 50.98 | -25.71 | 0 | 0 |
| 2016 (3) | 0.51 | -31.08 | 0.05 | 0.0 | 0.42 | -14.29 | 0.35 | 12.9 | 9.80 | 45.1 | 82.35 | 24.37 | 68.63 | 63.82 | 42 | 0.0 |
| 2015 (2) | 0.74 | -12.94 | 0.05 | -16.67 | 0.49 | -3.92 | 0.31 | 10.71 | 6.76 | -4.28 | 66.22 | 10.36 | 41.89 | 27.17 | 42 | 0.0 |
| 2014 (1) | 0.85 | 8.97 | 0.06 | -14.29 | 0.51 | 10.87 | 0.28 | 47.37 | 7.06 | 0 | 60.00 | 0 | 32.94 | 0 | 42 | 0.0 |
